Jmjd3 activates the expression of Mmp-2, -3, and -9 in bEnd.3 cells after hypoxia.
Silencing Jmjd3 inhibits the expression and activation of MMP-3 and MMP-9 after SCI.
Silencing Jmjd3 inhibits blood–spinal cord barrier disruption after SCI.
Silencing Jmjd3 inhibits neuronal death and improves functional recovery after SCI.